UK plan for national mRNA cancer-vaccine advance

UK plan for national mRNA cancer-vaccine advance External link

The UK is embarking on an ambitious plan to accelerate research into mRNA cancer vaccines, with German pharmaceutical company BioNTech. Following the success of Covid vaccines using the same messenger-ribonucleic-acid technology, scientists now want to conduct more trials in cancer patients.

Tagscancermedicinevaccine
Content typeLINK